Successful treatment of a therapy-resistant severely pruritic skin eruption of malignancy-associated dermatomyositis with high-dose intravenous immunoglobulin

Katsuko Kikuchi-Numagami, Maki Sato, Hachiro Tagami

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Malignancy-associated dermatomyositis developing in a middle-aged Japanese female was successfully treated by removal of her gastric cancer. However, five years later, concomitant with catching a cold, her severely pruritic skin lesions recurred on exposed areas. Six years after the start of corticosteroid therapy for her annoying skin lesion, we started to treat her with high-dose intravenous immunoglobulin (IVIG) infusion therapy because of the difficulty of reducing the dosage of oral prednisone, that had secondarily induced adverse effects. After five courses of the therapy, her recalcitrant, pruritic, erythematous skin lesions improved dramatically, enabling a satisfactory reduction in the dosage of oral prednisone. There were no significant adverse side effects with IVIG.

Original languageEnglish
Pages (from-to)340-343
Number of pages4
JournalJournal of Dermatology
Volume23
Issue number5
DOIs
Publication statusPublished - 1996 May

Keywords

  • amyopathic dermatomyositis
  • dermatomyositis
  • gammaglobulin
  • malignancy- associated dermatomyositis

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Successful treatment of a therapy-resistant severely pruritic skin eruption of malignancy-associated dermatomyositis with high-dose intravenous immunoglobulin'. Together they form a unique fingerprint.

Cite this